EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A Review of the Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Nonhematologic Malignancies

Defne Cigdem Koc, Ion Bogdan Mănescu iD, Măriuca Mănescu iD, Minodora Dobreanu iD

Diagnostics · 16.09.2024 · 14 (18) · 2057

DOI: 10.3390/diagnostics14182057 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 16.09.2024. Verfasst von Defne Cigdem Koc und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical Campus Hamburg, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 11-15 Albert-Einstein-Ring, 2276…. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biomarkers are crucial in cancer diagnostics, prognosis, and surveillance. Extensive research has been dedicated to identifying biomarkers that are broadly applicable across multiple cancer types and can be easily obtained from routine investigations such as blood cell counts. One such biomarker, the neutrophil-to-lymphocyte ratio (NLR), has been established as a prognostic marker in cancer. However, due to the dynamic nature of cancer diagnosis and treatment, periodic updates are necessary to keep abreast of the vast amount of published data. In this review, we searched the PubMed database and analyzed and synthesized recent literature (2018–February 2024) on the role of NLR in predicting clinical outcomes in nonhematologic malignancies. The search was conducted using the PubMed database. We included a total of 88 studies, encompassing 28,050 human subjects, and categorized the findings into four major groups: gastrointestinal cancer, cancers of the urinary tract and reproductive system, lung cancer, and breast cancer. Our analysis confirms that NLR is a reliable prognostic indicator in cancer, and we discuss the specific characteristics, limitations, and exceptions associated with its use. The review concludes with a concise Q&A section, presenting the most relevant take-home messages in response to five key practical questions on this topic.

Schlagwörter

Stichwörter der Autor:innen

NLRcancerclinical outcomeneutrophil-to-lymphocyte rationonhematologic malignancyprognosis

Autor:innen und Institutionen

  • Medical Campus Hamburg, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 11-15 Albert-Einstein-Ring, 22761 Hamburg, Germany.
  • Department of Laboratory Medicine, Faculty of Medicine, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 38 Gheorghe Marinescu, 540142 Targu Mures, Romania.
  • Department of Pediatrics, Emergency County Clinical Hospital of Targu Mures, 50 Gheorghe Marinescu, 540136 Targu Mures, Romania.
  • Clinical Laboratory, Emergency County Clinical Hospital of Targu Mures, 50 Gheorghe Marinescu, 540136 Targu Mures, Romania.

ORCID-Profile: Ion Bogdan Mănescu, Măriuca Mănescu, Minodora Dobreanu

Zitieren

APA

Koc, D. C., Mănescu, I. B., Mănescu, M., & Dobreanu, M. (2024). A Review of the Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Nonhematologic Malignancies. Diagnostics, 14(18), 2057. https://doi.org/10.3390/diagnostics14182057

Vancouver

Koc DC, Mănescu IB, Mănescu M, Dobreanu M. A Review of the Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Nonhematologic Malignancies. Diagnostics. 2024;14(18):2057. doi:10.3390/diagnostics14182057

BibTeX
@article{Koc2024,
  author = {Koc, Defne Cigdem and Mănescu, Ion Bogdan and Mănescu, Măriuca and Dobreanu, Minodora},
  title = {A Review of the Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Nonhematologic Malignancies},
  journal = {Diagnostics},
  year = {2024},
  volume = {14},
  number = {18},
  pages = {2057},
  doi = {10.3390/diagnostics14182057}
}
Kostenlos starten →